Lucid Diagnostics’ Initial Public Offering

Sonia Carcano North America Legal Chronicle
Tagged:

Friedman Kaplan advised PAVmed Inc. and its majority-owned subsidiary Lucid Diagnostics Inc. on the public offering. Lucid Diagnostics Inc. (Nasdaq: LUCD),  a commercial-stage, cancer prevention medical diagnostics…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here